PTCOG62 Conference Overview
The PTCOG62 Conference is the 62nd annual meeting of the Particle Therapy Cooperative Group (PTCOG). This premier event in the field of particle therapy gathers experts, practitioners, and researchers worldwide to discuss the latest advancements, research findings, and clinical practices in proton and carbon ion therapy. Read more about PTCOG62.
GSI Role
Participating in the PTCOG62 Conference held from June 10-15 in Singapore, as a partner in the HITRIplus project, was a significant opportunity to engage with the latest advancements and discussions in ion therapy. Within HITRIplus, our focus was on:
- Evaluating Technologies: Assessing their suitability for industry to enhance European market competitiveness.
- Facilitating Industry Partnerships: Defining the market position of project technologies by engaging with present companies, presenting value propositions that emphasize reduced costs and improved efficiency.
- Technology Matching: Connecting project technologies with interested industrial partners to foster collaborations, aiming to advance the adoption of a new generation of compact instruments in the global ion therapy market.
Key Highlights
The PTCOG62 Conference showcased significant breakthroughs in ion therapy technologies, particularly advancements in heavy ion arc therapy and patient positioning. These innovations are setting new benchmarks in cancer care and are poised to enhance patient outcomes worldwide significantly.
Clinical Advancements
Recent developments discussed at PTCOG62 highlighted the transformative impact of particle therapies on clinical outcomes. These advancements are shaping the evolving landscape of cancer treatment and underlining the growing role of ion therapy in personalized care strategies. Learn more about clinical advancements.
AI Integration
The establishment of a new AI sub-committee at PTCOG62 signifies a strategic move towards integrating artificial intelligence into ion therapy research, treatment planning, and patient care. A key focus area introduced was the first application of AI for Carbon-ion (RBE)-weighted dose calculation. This AI-driven approach aims to enhance dose calculation accuracy, leading to more effective and personalized cancer treatments. Explore AI’s role in ion therapy.
My Role at GSI Helmholtz Centre for Heavy Ion Research
As an Innovation Manager within the Technology Transfer Office (TTR) at the GSI Helmholtz Centre for Heavy Ion Research, I had the privilege of contributing to the HITRIplus project, funded by the European Union’s Horizon 2020 research and innovation program. This experience provided invaluable insights into the intersection of advanced scientific research and its practical applications in industry.
Key Experiences and Learnings
- Understanding the Value Proposition: I mastered the Value Proposition Method and Canvas, which were crucial for articulating the unique benefits and competitive advantages of HITRIplus technologies. This process was key in aligning technological advancements with market needs, particularly within EU-funded projects where impact and sustainability are paramount.
- Technology Transfer Processes: I gained a deep understanding of technology transfer, including intellectual property management, commercialization support, and industry collaboration. This highlighted the strategic importance of leveraging intellectual property within scientific research.
- Promotional Activities and Industry Engagement: I developed promotional materials, participated in technology-matching events, and engaged with industry stakeholders. This experience emphasized the necessity of clear communication and strategic marketing in promoting technological innovations.
Attending the PTCOG62 Conference in Singapore was a professional highlight, offering a platform to showcase advancements in ion therapy and discuss their clinical implications, particularly the transformative impact of particle therapies on cancer treatment.
This role significantly contributed to my professional development, equipping me with essential skills in market analysis, business development, and technology evaluation. Collaborating with professionals from diverse backgrounds enriched my understanding of interdisciplinary teamwork and strategic planning.
In conclusion, my work within the HITRIplus project has been an invaluable experience, shaping my career aspirations and providing critical skills and knowledge in technology transfer and market integration.
Written by Jelena Bardak
Innovation Manager at Technology Transfer Department
PhD student in Nuclear Physics
GSI Helmholtzzentrum für Schwerionenforschung GmbH
Plankstrasse 1, Darmstadt
